120 related articles for article (PubMed ID: 27165274)
1. [Immunomodulation and neuroprotection in optic neuritis].
Beisse F; Diem R
Ophthalmologe; 2016 May; 113(5):398-401. PubMed ID: 27165274
[TBL] [Abstract][Full Text] [Related]
2. [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].
Heiligenhaus A; Tappeiner C; Walscheid K; Heinz C
Ophthalmologe; 2016 May; 113(5):391-7. PubMed ID: 27142035
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
Pleyer U; Pohlmann D; Stübiger N
Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Sühs KW; Hein K; Sättler MB; Görlitz A; Ciupka C; Scholz K; Käsmann-Kellner B; Papanagiotou P; Schäffler N; Restemeyer C; Bittersohl D; Hassenstein A; Seitz B; Reith W; Fassbender K; Hilgers R; Heesen C; Bähr M; Diem R
Ann Neurol; 2012 Aug; 72(2):199-210. PubMed ID: 22926853
[TBL] [Abstract][Full Text] [Related]
5. Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Sättler MB; Williams SK; Neusch C; Otto M; Pehlke JR; Bähr M; Diem R
Am J Pathol; 2008 Nov; 173(5):1496-507. PubMed ID: 18832577
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune optic neuritis].
Kerty E; Aanonsen NO; Nyberg-Hansen R
Tidsskr Nor Laegeforen; 1992 Jan; 112(3):335-6. PubMed ID: 1553669
[TBL] [Abstract][Full Text] [Related]
7. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
[TBL] [Abstract][Full Text] [Related]
8. Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Aktas O; Albrecht P; Hartung HP
Curr Opin Neurol; 2016 Jun; 29(3):199-204. PubMed ID: 27035900
[TBL] [Abstract][Full Text] [Related]
9. An optical coherence tomography study on degeneration of retinal nerve fiber layer in rats with autoimmune optic neuritis.
Hein K; Gadjanski I; Kretzschmar B; Lange K; Diem R; Sättler MB; Bähr M
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):157-63. PubMed ID: 22131393
[TBL] [Abstract][Full Text] [Related]
10. [Immunomodulatory therapy of autoimmune diseases : Quo vadis?].
Hoyer BF; Hiepe F
Ophthalmologe; 2016 May; 113(5):373-9. PubMed ID: 27155599
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Shayegannejad V; Shahzamani S; Dehghani A; Dast Borhan Z; Rahimi M; Mirmohammadsadeghi A
Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):797-801. PubMed ID: 25605544
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effects of Novel Treatments on Acute Optic Neuritis-A Meta-Analysis.
Tsai TH; Lin CW; Chan LW; Tew TB; Chen TC
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052875
[TBL] [Abstract][Full Text] [Related]
13. [Blistering autoimmune dermatoses (II): therapy].
Goebeler M; Sitaru C; Zillikens D
J Dtsch Dermatol Ges; 2004 Sep; 2(9):774-91; quiz 792-3. PubMed ID: 16279223
[No Abstract] [Full Text] [Related]
14. Winning combination: the additive/synergistic benefits of IVIg in corticosteroid refractory optic neuritis.
Achiron A
Eur J Neurol; 2008 Nov; 15(11):1145. PubMed ID: 18973610
[No Abstract] [Full Text] [Related]
15. Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial.
McKee JB; Cottriall CL; Elston J; Epps S; Evangelou N; Gerry S; Kennard C; Kong Y; Koelewyn A; Kueker W; Leite MI; Palace J; Craner M
Mult Scler; 2019 Feb; 25(2):246-255. PubMed ID: 29172994
[TBL] [Abstract][Full Text] [Related]
16. Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin.
Tselis A; Perumal J; Caon C; Hreha S; Ching W; Din M; Van Stavern G; Khan O
Eur J Neurol; 2008 Nov; 15(11):1163-7. PubMed ID: 18727675
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis.
Knier B; Rothhammer V; Heink S; Puk O; Graw J; Hemmer B; Korn T
J Autoimmun; 2015 Jan; 56():34-44. PubMed ID: 25282335
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis.
Sühs KW; Fairless R; Williams SK; Heine K; Cavalié A; Diem R
J Neuropathol Exp Neurol; 2014 Jun; 73(6):507-18. PubMed ID: 24806299
[TBL] [Abstract][Full Text] [Related]
19. [Steroids for optic nerve diseases?].
Lagrèze WA
Ophthalmologe; 2007 Jun; 104(6):517-20. PubMed ID: 17486348
[TBL] [Abstract][Full Text] [Related]
20. [Bilateral recurrent autoimmune optical neuropathy in childhood].
García-Gómez PJ; Belzunce A; Salinas Alamán A; Heras H; Sádaba LM
Arch Soc Esp Oftalmol; 2006 Oct; 81(10):607-10. PubMed ID: 17075764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
